Sand Grove Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$1.21M 25
2023
Q4
$1.21M Buy
+20,000
New +$1.21M 0.32% 17